VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RLIRLI Corp.
$58.40$5.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRLIFinancials

RLI Corp. (RLI) Financials

30Y historyFree accessUpdated daily

Revenue growth remains highly cyclical, fluctuating from a 41.7% surge in 2024Q3 to an 8.4% contraction in 2025Q1, while underwriting profitability remains resilient with a combined ratio that reached a low of 64.0% in 2024Q1.

RLI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.9B1.88B1.77B1.51B1.7B1.18B987.68M1.01B820.36M800.8M817.85M796.47M777.12M707.73M662.71M621.38M585.63M548.55M561.01M652.35M632.71M569.3M578.8M519.89M382.15M309.35M263.5M225.76M168.11M170.5M155.35M
Revenue Growth %9.54%6.33%17.09%-10.95%43.47%19.83%-1.88%22.7%2.44%-2.09%2.68%2.49%9.81%6.79%6.65%6.1%6.76%-2.22%-14%3.1%11.14%-1.64%11.33%36.04%23.53%17.4%16.72%34.29%-1.4%9.75%-0.86%
Medical Costs & Claims1.19B1.32B1.32B1.12B966.22M723.95M679.92M651.15M640.94M605.29M544.21M486.01M480.59M429.22M426.66M343.56M392.25M396.46M410.49M346.48M402.67M387.23M440.73M398.27M308.67M246.78M201.04M163.01M109.01M104.35M97.82M
Medical Cost Ratio %62.49%70.18%74.32%74.15%56.9%61.17%68.84%64.69%78.13%75.59%66.54%61.02%61.84%60.65%64.38%55.29%66.98%72.27%73.17%53.11%63.64%68.02%76.14%76.61%80.77%79.77%76.3%72.21%64.84%61.2%62.96%
Gross Profit712.18M561.42M454.63M390.87M731.77M459.6M307.76M355.47M179.43M195.51M273.64M310.46M296.53M278.51M236.05M277.81M193.38M152.09M150.52M305.87M230.04M182.07M138.07M121.61M73.49M62.57M62.46M62.75M59.1M66.15M57.54M
Gross Margin %37.51%29.82%25.68%25.85%43.1%38.83%31.16%35.31%21.87%24.41%33.46%38.98%38.16%39.35%35.62%44.71%33.02%27.73%26.83%46.89%36.36%31.98%23.86%23.39%19.23%20.23%23.7%27.79%35.16%38.8%37.04%
Gross Profit Growth %-23.49%16.31%-46.59%59.22%49.34%-13.42%98.12%-8.23%-28.55%-11.86%4.7%6.47%17.98%-15.03%43.66%27.14%1.05%-50.79%32.96%26.35%31.87%13.53%65.49%17.44%0.19%-0.46%6.16%-10.65%14.97%106.89%
Operating Expenses205.2M43.15M27.08M13.61M11.09M115.28M117.92M122.74M111.84M110.92M116.56M113.78M107.05M102.84M93.32M94.22M14.89M19.65M43.92M51.39M43.15M38.2M37.73M27.34M24.76M21.56M24.16M19.71M21.38M-55.55M22.3M
OpEx / Revenue %10.81%2.29%1.53%0.9%0.65%9.74%11.94%12.19%13.63%13.85%14.25%14.29%13.77%14.53%14.08%15.16%2.54%3.58%7.83%7.88%6.82%6.71%6.52%5.26%6.48%6.97%9.17%8.73%12.72%-32.58%14.35%
Depreciation & Amortization08.13M7.66M8.54M7.98M7.39M7.43M8.16M7.04M6.94M6.43M5.41M4.56M3.77M3.15M3.18M3.04M3.28M3.6M3.57M3.5M3.23M3.03M3.23M3.55M3.28M3.09M2.66M2.07M2.3M2.5M
Combined Ratio %73.3%72.47%75.85%75.05%57.56%70.91%80.78%76.88%91.76%89.44%80.79%75.31%75.62%75.18%78.46%70.45%69.52%75.86%81%60.99%70.46%74.73%82.66%81.87%87.25%86.74%85.47%80.94%77.56%28.62%77.32%
Operating Income506.98M518.27M427.55M377.26M720.68M344.32M189.84M232.73M67.58M84.59M157.08M196.68M189.49M175.67M142.73M183.59M178.49M132.44M106.6M254.48M186.89M143.88M100.34M94.28M48.73M41.02M38.29M43.03M37.72M121.7M35.24M
Operating Margin %26.7%27.53%24.15%24.95%42.44%29.09%19.22%23.12%8.24%10.56%19.21%24.69%24.38%24.82%21.54%29.55%30.48%24.14%19%39.01%29.54%25.27%17.34%18.13%12.75%13.26%14.53%19.06%22.44%71.38%22.68%
Operating Income Growth %-21.22%13.33%-47.65%109.3%81.37%-18.43%244.38%-20.11%-46.15%-20.13%3.8%7.87%23.07%-22.25%2.86%34.77%24.24%-58.11%36.16%29.9%43.39%6.43%93.48%18.8%7.12%-11.02%14.09%-69%245.35%-67.46%
EBITDA512.05M526.4M435.21M385.81M728.66M351.71M197.27M240.9M74.62M91.53M163.51M202.09M194.04M179.43M145.88M186.76M181.53M135.72M110.19M258.04M190.4M147.1M103.38M97.51M52.27M44.3M41.38M45.7M39.79M124M37.74M
EBITDA Margin %26.97%27.96%24.58%25.52%42.91%29.72%19.97%23.93%9.1%11.43%19.99%25.37%24.97%25.35%22.01%30.06%31%24.74%19.64%39.56%30.09%25.84%17.86%18.76%13.68%14.32%15.71%20.24%23.67%72.73%24.29%
Interest Expense6.38M5.36M6.33M7.3M8.05M7.68M7.6M7.59M7.44M7.43M7.43M7.43M7.44M8.1M6.05M6.05M6.05M6.05M6.7M7M6.58M7.12M6.89M1.01M1.86M3.21M5.28M4.1M2.28M1.5M2.81M
Non-Operating Income-5.07M-4.05M-6.33M-7.3M-8.05M-7.68M-7.6M-7.59M-7.44M-7.43M-7.43M-7.43M-7.44M-8.1M-6.05M-6.05M-6.05M-6.05M-6.7M-7M-6.58M-7.12M-6.89M-1.01M-1.86M-3.21M-5.28M-4.1M-2.28M120.2M-2.81M
Pretax Income494.69M505.98M427.55M377.26M720.68M344.32M189.84M232.73M67.58M84.59M157.08M196.68M189.49M175.67M142.73M183.59M178.49M132.44M106.6M254.48M186.89M143.88M100.34M94.28M48.73M41.02M38.29M43.03M37.72M41.6M35.24M
Pretax Margin %26.05%26.88%24.15%24.95%42.44%29.09%19.22%23.12%8.24%10.56%19.21%24.69%24.38%24.82%21.54%29.55%30.48%24.14%19%39.01%29.54%25.27%17.34%18.13%12.75%13.26%14.53%19.06%22.44%24.4%22.68%
Income Tax99.68M102.64M81.77M72.65M137.27M64.97M32.75M41.09M3.4M-20.44M42.16M59.14M54.04M49.41M39.39M56.99M51.06M38.59M27.92M78.61M52.25M36.74M27.31M22.99M12.88M10.77M9.6M11.58M9.48M11.4M9.54M
Effective Tax Rate %20.15%20.29%19.13%19.26%19.05%18.87%17.25%17.66%5.03%-24.16%26.84%30.07%28.52%28.13%27.59%31.04%28.61%29.14%26.19%30.89%27.96%25.54%27.21%24.38%26.42%26.26%25.07%26.92%25.14%27.4%27.08%
Net Income395.01M403.34M345.78M304.61M583.41M279.35M157.09M191.64M64.18M105.03M114.92M137.54M135.44M126.25M103.35M126.6M127.43M93.84M78.68M175.87M134.64M107.13M73.04M71.29M35.85M31.05M28.69M31.45M28.24M30.2M25.7M
Net Margin %20.8%21.43%19.53%20.15%34.36%23.6%15.91%19.04%7.82%13.12%14.05%17.27%17.43%17.84%15.59%20.37%21.76%17.11%14.02%26.96%21.28%18.82%12.62%13.71%9.38%10.04%10.89%13.93%16.8%17.71%16.54%
Net Income Growth %40.53%16.65%13.51%-47.79%108.84%77.83%-18.03%198.61%-38.89%-8.61%-16.45%1.55%7.28%22.17%-18.37%-0.65%35.79%19.28%-55.26%30.62%25.67%46.69%2.45%98.85%15.48%8.2%-8.77%11.37%-6.49%17.53%225.26%
EPS (Diluted)4.284.363.743.316.373.061.732.120.721.181.301.561.551.291.201.531.501.080.901.831.321.020.700.690.440.390.360.390.330.340.29
EPS Growth %40.79%16.58%12.99%-48.04%108.17%76.88%-18.4%196.5%-39.41%-8.88%-16.99%0.97%20.23%7.08%-21.31%1.67%38.89%20%-50.68%38.26%29.41%45.71%1.45%56.82%12.82%8.33%-6.49%16.67%-1.49%17.54%185%
EPS (Basic)-4.383.783.346.433.091.752.140.721.191.311.561.571.471.221.551.521.090.921.871.351.060.730.710.450.400.370.390.340.370.33
Diluted Shares Outstanding92.19M92.22M92.45M92.15M91.59M91.42M90.75M90.51M89.67M89M88.86M88.26M87.64M87.03M86.32M85.74M84.96M86.92M87.39M96.34M102.28M105.3M104.37M103.38M82.05M80.02M79.56M81.78M85.1M90.83M96.66M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Catastrophe exposure and inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Volatile Premium Growth Trends Observed

As evidenced by the quarterly financial data, RLI's revenue growth has exhibited significant volatility, ranging from a 41.7% surge in 2024Q3 to an 8.4% contraction in 2025Q1, suggesting that the company's niche-focused underwriting model is highly sensitive to cyclical shifts in specific specialty insurance markets.

The erratic top-line performance implies that RLI's decentralized product manager model may prioritize underwriting discipline over consistent premium volume growth. Investors should monitor whether these fluctuations represent a strategic choice to exit underpriced segments or a broader softening in demand for specialized surety and casualty products.

Underwriting Profitability Remains Highly Resilient

Based on the reported combined ratios, which reached a low of 64.0% in 2024Q1, RLI consistently demonstrates superior underwriting profitability, maintaining a combined ratio well below the 100% threshold despite the inherent volatility associated with its property and casualty insurance segments across the observed ten-quarter period.

The ability to maintain such favorable combined ratios suggests that RLI's decentralized underwriting structure effectively filters out high-risk, low-margin business. This operational efficiency appears to be a core driver of the company's valuation premium, though the recent uptick in loss ratios warrants further investigation into potential claims inflation.

Catastrophe Impact Distorts Quarterly Earnings

Financial statements indicate that RLI experienced a notable inflection point in 2024Q4, where the loss ratio spiked to 85.4% and net income dropped to $40.9M, highlighting the company's vulnerability to periodic catastrophe events that can temporarily overwhelm the underwriting gains typically generated by the surety segment.

This period serves as a stark reminder that RLI's property exposure remains a significant source of earnings volatility. While the company recovered quickly in subsequent quarters, the event underscores the necessity of analyzing RLI's performance through a multi-year lens rather than relying on short-term quarterly results.

Reserve Development Quality Requires Scrutiny

According to the provided income statement data, the significant variance in quarterly loss ratios, such as the shift from 32.2% in 2023Q4 to 85.4% in 2024Q4, suggests that RLI's reported earnings may be heavily influenced by the timing of reserve adjustments rather than pure current-year underwriting performance.

Investors should be cautious, as favorable reserve releases from prior years can mask underlying deterioration in current-year underwriting margins. The lack of explicit disclosure regarding reserve development makes it difficult to determine if the current profitability is sustainable or if it relies on the exhaustion of conservative past estimates.

RLI — Frequently Asked Questions

Quick answers to the most common questions about buying RLI stock.

What was RLI Corp.'s (RLI) revenue in 2025?

For fiscal year 2025, RLI Corp. (RLI) reported total revenue of $1.88B. This represents a 1111.7% increase compared to $155.4M in 1996.

Is RLI Corp. (RLI) profitable?

RLI Corp. (RLI) is profitable, generating $403.3M in net income for the fiscal year ending 2025 with a net profit margin of 21.4%.

What is RLI Corp.'s operating profit margin?

RLI Corp. (RLI) reported an operating income of $518.3M, resulting in an operating profit margin of 27.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is RLI Corp.'s gross profit and gross margin?

RLI Corp. (RLI) generated $561.4M in gross profit for the year, representing a gross profit margin of 29.8%. This demonstrates the company's core pricing power and production efficiency.